XML 55 R2.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Pay vs Performance Disclosure | 12 Months Ended
--- | ---
Dec. 31, 2023 USD ($) uS_Dollar_Per_Share | Dec. 31, 2022 USD ($) uS_Dollar_Per_Share | Dec. 31, 2021 USD ($) uS_Dollar_Per_Share | Dec. 31, 2020 USD ($) uS_Dollar_Per_Share
Pay vs Performance Disclosure |  |  |  |
Pay vs Performance Disclosure, Table | Mr. Cordani:
Fiscal Year | Summary Compensation Table Total |  | Compensation Actually Paid |  | Ratio of Compensation Actually Paid to Summary Compensation Table Total
2023 | $21,047,255 |  | $8,153,258 |  | 0.39
2022 | $20,965,504 |  | $57,388,994 |  | 2.74
2021 | $19,872,266 |  | $15,448,906 |  | 0.78
2020 | $19,929,493 |  | $15,872,537 |  | 0.80
Other NEOs:
Fiscal Year | Summary Compensation Table Total |  | Compensation Actually Paid |  | Ratio of Compensation Actually Paid to Summary Compensation Table Total
2023 | $6,801,329 |  | $3,521,133 |  | 0.52
2022 | $6,346,552 |  | $15,496,862 |  | 2.44
2021 | $7,164,215 |  | $5,232,498 |  | 0.73
2020 | $7,075,762 |  | $5,955,295 |  | 0.84
| Summary Compensation Table Total for Mr. Cordani ($) | Compensation Actually Paid to Mr. Cordani ($) | Average Summary Compensation Table Total for NEOs (other than Mr. Cordani) ($) | Average Compensation Actually Paid to NEOs (other than Mr. Cordani) ($) |  | Value of Initial Fixed $100 Investment Based On: | Net Income(2) (in millions) ($) | Company -Selected Measure: Adjusted Income from Operations, per share (3) ($)
Fiscal Year |  | Company TSR ($) |  | Peer Group TSR(1) ($)
(b) | (c) | (d) | (e) |  | (f) |  | (g) | (h) | (i)
2023 | $21,047,255 | $8,153,258 | $6,801,329 | $3,521,133 |  | 154.34 |  | 143.18 | 5,164 | 25.09
2022 | $20,965,504 | $57,388,994 | $6,346,552 | $15,496,862 |  | 167.71 |  | 140.29 | 6,704(4) | 23.36(4)
2021 | $19,872,266 | $15,448,906 | $7,164,215 | $5,232,498 |  | 114.34 |  | 143.09 | 5,370(4) | 20.48(4)
2020 | $19,929,493 | $15,872,537 | $7,075,762 | $5,955,295 |  | 101.83 |  | 113.45 | 8,458 | 18.45
Company Selected Measure Name | Adjusted Income from Operations, per share |  |  |
Named Executive Officers, Footnote | The NEOs (other than Mr. Cordani) reflected in columns (d) and (e) of the Pay Versus Performance Table are represented by the following individuals for each fiscal year as shown below:
2023 | 2022 | 2021 | 2020
Brian C. Evanko | Brian C. Evanko | Brian C. Evanko | Eric P. Palmer
Noelle K. Eder | Noelle K. Eder | Nicole S. Jones | Nicole S. Jones
Nicole S. Jones | Nicole S. Jones | Eric P. Palmer | Timothy Wentworth
Eric P. Palmer | Eric P. Palmer | Timothy Wentworth | Matthew Manders
|  | Matthew Manders |
Peer Group Issuers, Footnote | Peer Group reflects published data for the S&P 500 Health Care Index. |  |  |
PEO Total Compensation Amount | $ 21,047,255 | $ 20,965,504 | $ 19,872,266 | $ 19,929,493
PEO Actually Paid Compensation Amount | $ 8,153,258 | 57,388,994 | 15,448,906 | 15,872,537
Adjustment To PEO Compensation, Footnote | To calculate the Compensation Actually Paid reflected in the Pay Versus Performance Table above, the following amounts were deducted from and added to the Summary Compensation Table total compensation for each fiscal year: Mr. Cordani’s Summary Compensation Table Total to Compensation Actually Paid Reconciliation
Fiscal Year | Salary ($) | Stock Awards ($) | Bonus & Non-Equity Incentive Comp. ($) | All Other Comp. ($) | Change in Pension Value & NQDC Earnings ($) | Summary Comp. Table Total ($) | Stock Award Deductions from Summary Comp. Table Total(1) ($) | Stock Award Additions to Summary Comp. Table Total(2) ($) | Comp. Actually Paid(3) ($)
2023 | $1,500,000 | $15,856,233 | $3,300,000 | $310,437 | $80,585 | $21,047,255 | $(15,856,233) | $2,962,236 | $8,153,258
2022 | $1,500,000 | $15,544,307 | $3,600,000 | $321,197 | $0 | $20,965,504 | $(15,544,307) | $51,967,797 | $57,388,994
2021 | $1,500,000 | $15,370,427 | $2,700,000 | $301,839 | $0 | $19,872,266 | $(15,370,427) | $10,947,067 | $15,448,906
2020 | $1,500,000 | $14,560,254 | $3,500,000 | $179,341 | $189,898 | $19,929,493 | $(14,560,254) | $10,503,298 | $15,872,537
Represents the grant date fair value of equity-based awards granted each year. (2)Reflects the value of equity calculated in accordance with the SEC methodology for determining Compensation Actually Paid for each year shown. The equity component of Compensation Actually Paid for each fiscal year is further detailed in the tables below: Mr. Cordani’s Compensation Actually Paid Equity Valuation for Each Fiscal Year 2023 Compensation Actually Paid Equity Valuation
Award Type | Fair Value of Awards Granted in Current Year Outstanding and Unvested as of 12/31/2023 ($) | Change in Fair Value of Outstanding and Unvested Prior Year Awards as of 12/31/2023 ($) | Change in Fair Value of Awards that Vested in 2023 ($) | Fair Value of Awards Forfeited or Cancelled in 2023 ($) | Equity Value in Compensation Actually Paid ($)
(a) | (b) | (c) | (d) | (e) = (a) + (b) + (c) - (d)
Stock Options | $3,106,749 | $(2,098,800) | $(2,374,503) | $0 | $(1,366,555)
Restricted Stock | $3,252,626 | $(451,849) | $(640,466) | $0 | $2,160,310
Strategic Perf Shares | $8,773,351 | $(5,212,929) | $(1,391,941) | $0 | $2,168,481
Total | $15,132,725 | $(7,763,578) | $(4,406,911) | $0 | $2,962,236
2022 Compensation Actually Paid Equity Valuation
Award Type | Fair Value of Awards Granted in Current Year Outstanding and Unvested as of 12/31/2022 ($) | Change in Fair Value of Outstanding and Unvested Prior Year Awards as of 12/31/2022 ($) | Change in Fair Value of Awards that Vested in 2022 ($) | Fair Value of Awards Forfeited or Cancelled in 2022 ($) | Equity Value in Compensation Actually Paid ($)
(a) | (b) | (c) | (d) | (e) = (a) + (b) + (c) - (d)
Stock Options | $7,876,809 | $6,875,723 | $444,986 | $0 | $15,197,518
Restricted Stock | $4,232,869 | $1,767,720 | $38,838 | $0 | $6,039,426
Strategic Perf Shares | $17,751,119 | $12,979,546 | $188 | $0 | $30,730,853
Total | $29,860,797 | $21,622,989 | $484,012 | $0 | $51,967,797
2021 Compensation Actually Paid Equity Valuation
Award Type | Fair Value of Awards Granted in Current Year Outstanding and Unvested as of 12/31/2021 ($) | Change in Fair Value of Outstanding and Unvested Prior Year Awards as of 12/31/2021 ($) | Change in Fair Value of Awards that Vested in 2021 ($) | Fair Value of Awards Forfeited or Cancelled in 2021 ($) | Equity Value in Compensation Actually Paid ($)
(a) | (b) | (c) | (d) | (e) = (a) + (b) + (c) - (d)
Stock Options | $4,385,246 | $382,720 | $(555,181) | $0 | $4,212,785
Restricted Stock | $3,893,606 | $392,213 | $26,005 | $0 | $4,311,824
Strategic Perf Shares | $6,977,016 | $(4,619,317) | $64,758 | $0 | $2,422,457
Total | $15,255,868 | $(3,844,384) | $(464,418) | $0 | $10,947,067
2020 Compensation Actually Paid Equity Valuation
Award Type | Fair Value of Awards Granted in Current Year Outstanding and Unvested as of 12/31/2020 ($) | Change in Fair Value of Outstanding and Unvested Prior Year Awards as of 12/31/2020 ($) | Change in Fair Value of Awards that Vested in 2020 ($) | Fair Value of Awards Forfeited or Cancelled in 2020 ($) | Equity Value in Compensation Actually Paid ($)
(a) | (b) | (c) | (d) | (e) = (a) + (b) + (c) - (d)
Stock Options | $3,749,535 | $(241,674) | $(1,637,861) | $0 | $1,870,000
Restricted Stock | $3,794,705 | $45,261 | $(114,871) | $0 | $3,725,095
Strategic Perf Shares | $7,929,201 | $(1,965,506) | $(1,055,492) | $0 | $4,908,203
Total | $15,473,441 | $(2,161,919) | $(2,808,224) | $0 | $10,503,298
No pension-related adjustments associated with the Cigna Pension Plan were necessary in the calculation of Compensation Actually Paid as the plan is frozen and there were no prior service costs established in the last three years. |  |  |
Non-PEO NEO Average Total Compensation Amount | $ 6,801,329 | 6,346,552 | 7,164,215 | 7,075,762
Non-PEO NEO Average Compensation Actually Paid Amount | $ 3,521,133 | 15,496,862 | 5,232,498 | 5,955,295
Adjustment to Non-PEO NEO Compensation Footnote | To calculate the Compensation Actually Paid reflected in the Pay Versus Performance Table above, the following amounts were deducted from and added to the Summary Compensation Table total compensation for each fiscal year: Average NEOs’ (other than Mr. Cordani) Summary Compensation Table Total to Compensation Actually Paid Reconciliation
Fiscal Year | Salary ($) | Stock Awards ($) | Bonus & Non-Equity Incentive Comp. ($) | All Other Comp. ($) | Change in Pension Value & NQDC Earnings ($) | Summary Comp. Table Total ($) | Stock Award Deductions from Summary Comp. Table Total(1) ($) | Stock Award Additions to Summary Comp. Table Total(2) ($) | Comp. Actually Paid(3) ($)
2023 | $875,288 | $4,500,529 | $1,365,000 | $50,046 | $10,466 | $6,801,329 | $(4,500,529) | $1,220,332 | $3,521,133
2022 | $827,549 | $4,236,986 | $1,230,625 | $51,392 | $0 | $6,346,552 | $(4,236,986) | $13,387,296 | $15,496,862
2021 | $995,385 | $4,731,519 | $604,500 | $829,680 | $3,131 | $7,164,215 | $(4,731,519) | $2,799,802 | $5,232,498
2020 | $1,001,923 | $4,503,476 | $1,470,625 | $55,835 | $43,903 | $7,075,762 | $(4,503,476) | $3,383,009 | $5,955,295
(1)Represents the grant date fair value of equity-based awards granted each year. (2)Reflects the value of equity calculated in accordance with the SEC methodology for determining Compensation Actually Paid for each year shown. The equity component of Compensation Actually Paid for each fiscal year is further detailed in the tables below: Average NEO’s (other than Mr. Cordani) Compensation Actually Paid Equity Valuation for Each Fiscal Year 2023 Compensation Actually Paid Equity Valuation
Award Type | Fair Value of Awards Granted in Current Year Outstanding and Unvested as of 12/31/2023 ($) | Change in Fair Value of Outstanding and Unvested Prior Year Awards as of 12/31/2023 ($) | Change in Fair Value of Awards that Vested in 2023 ($) | Fair Value of Awards Forfeited or Cancelled in 2023 ($) | Equity Value in Compensation Actually Paid ($)
(a) | (b) | (c) | (d) | (e) = (a) + (b) + (c) - (d)
Stock Options | $1,100,520 | $(639,461) | $(594,895) | $0 | $(133,836)
Restricted Stock | $1,152,358 | $(138,275) | $(182,536) | $0 | $831,548
Strategic Perf Shares | $2,071,979 | $(1,252,141) | $(297,218) | $0 | $522,621
Total | $4,324,857 | $(2,029,877) | $(1,074,648) | $0 | $1,220,332
2022 Compensation Actually Paid Equity Valuation
Award Type | Fair Value of Awards Granted in Current Year Outstanding and Unvested as of 12/31/2022 ($) | Change in Fair Value of Outstanding and Unvested Prior Year Awards as of 12/31/2022 ($) | Change in Fair Value of Awards that Vested in 2022 ($) | Fair Value of Awards Forfeited or Cancelled in 2022 ($) | Equity Value in Compensation Actually Paid ($)
(a) | (b) | (c) | (d) | (e) = (a) + (b) + (c) - (d)
Stock Options | $2,714,064 | $1,556,183 | $91,685 | $0 | $4,361,932
Restricted Stock | $1,458,559 | $444,168 | $36,761 | $0 | $1,939,488
Strategic Perf Shares | $4,077,759 | $3,008,083 | $33 | $0 | $7,436,426
Total | $8,250,382 | $5,008,434 | $128,479 | $0 | $13,387,296
2021 Compensation Actually Paid Equity Valuation
Award Type | Fair Value of Awards Granted in Current Year Outstanding and Unvested as of 12/31/2021 ($) | Change in Fair Value of Outstanding and Unvested Prior Year Awards as of 12/31/2021 ($) | Change in Fair Value of Awards that Vested in 2021 ($) | Fair Value of Awards Forfeited or Cancelled in 2021 ($) | Equity Value in Compensation Actually Paid ($)
(a) | (b) | (c) | (d) | (e) = (a) + (b) + (c) - (d)
Stock Options | $1,349,900 | $84,814 | $(143,363) | $0 | $1,291,351
Restricted Stock | $1,198,577 | $132,175 | $(345,777) | $0 | $984,975
Strategic Perf Shares | $1,861,457 | $(1,240,350) | $49,621 | $147,252 | $523,476
Total | $4,409,934 | $(1,023,361) | $(439,519) | $147,252 | $2,799,802
2020 Compensation Actually Paid Equity Valuation
Award Type | Fair Value of Awards Granted in Current Year Outstanding and Unvested as of 12/31/2020 ($) | Change in Fair Value of Outstanding and Unvested Prior Year Awards as of 12/31/2020 ($) | Change in Fair Value of Awards that Vested in 2020 ($) | Fair Value of Awards Forfeited or Cancelled in 2020 ($) | Equity Value in Compensation Actually Paid ($)
(a) | (b) | (c) | (d) | (e) = (a) + (b) + (c) - (d)
Stock Options | $1,159,710 | $(52,264) | $(444,007) | $0 | $663,439
Restricted Stock | $1,173,719 | $35,275 | $(56,462) | $0 | $1,152,532
Strategic Perf Shares | $2,452,495 | $(533,442) | $(352,015) | $0 | $1,567,038
Total | $4,785,924 | $(550,431) | $(852,484) | $0 | $3,383,009
(3)No pension-related adjustments associated with the Cigna Pension Plan were necessary in the calculation of Compensation Actually Paid as the plan is frozen and there were no prior service costs established in the last three years. |  |  |
Compensation Actually Paid vs. Total Shareholder Return | Compensation Actually Paid versus Company TSR and Peer Group TSR From 2020 through 2023, Mr. Cordani and the other NEOs’ Compensation Actually Paid amounts were generally aligned with the Company’s absolute TSR and its relative TSR as compared to the peer group used for this Pay Versus Performance analysis, namely the S&P 500 Health Care Index. This is due primarily to the Company’s use of equity incentives, which are tied directly to the Company’s stock price and financial performance on an absolute basis and relative to its peers. In addition, 50% of an SPS award’s payout is aligned to relative TSR performance as compared to a custom peer group, which has changed over time and, for awards granted in 2020 and 2021, differs from the broader S&P 500 Health Care Index. The Company’s TSR underperformed relative to the S&P 500 Health Care Index in 2020 and 2021, leading to annual Compensation Actually Paid values that were lower than their relative Summary Compensation Table values in those fiscal years. In 2022, however, the Company saw significant TSR growth and outperformed the peer group. This stock price growth translated to significantly increased Compensation Actually Paid values for Mr. Cordani and the other NEOs for 2022. The Company’s TSR for 2023 was lower than the Company’s 2022 TSR on an absolute and relative basis, leading to Compensation Actually Paid values that were lower than both the Summary Compensation Table value for 2023 and the 2022 Compensation Actually Paid values. The graph below compares The Cigna Group cumulative TSR to the S&P 500 Index and the S&P 500 Health Care Index for the five-year period ended December 31, 2023, which we believe provides a more fulsome understanding of the Company’s market performance given the longer time horizon. The stock performance shown in the graph is not intended to forecast or be indicative of future performance. *Assumes that the value of the investment in Cigna common stock and each index was $100 on December 31, 2018 and that all dividends were reinvested. |  |  |
Compensation Actually Paid vs. Net Income | Compensation Actually Paid versus Net Income The Company’s annual net income in 2023 was slightly below 2022, primarily driven by the recognition of a loss on the sale of a business. Between 2020 and 2022, Mr. Cordani and other NEOs’ Compensation Actually Paid has generally appreciated, but decreased in 2023. This is due to the following: •the significant emphasis the Company places on equity incentives, which are more sensitive to absolute stock price performance and stock price performance relative to peers; and •the fact that the Company does not use year-over-year changes in net income to determine compensation levels or incentive plan payouts. Instead, adjusted income from operations has been the Company’s income measure of performance in its incentive plans and one of the Company’s most important performance measures for determining compensation. |  |  |
Compensation Actually Paid vs. Company Selected Measure | Compensation Actually Paid versus Adjusted Income from Operations per Share Similar to the discussion of the relationship between Compensation Actually Paid and Company/Peer Group TSR above, Mr. Cordani and other NEOs’ Compensation Actually Paid amounts are generally aligned with the Company’s adjusted income from operations per share results over the reporting period. Adjusted income from operations per share long-term goals account for 50% of each SPS award’s total payout. Final results for adjusted income from operations per shares in years 2021, 2022, and 2023, relative to internal goals established at the beginning of each SPS award’s performance measurement period, have contributed to the Compensation Actually Paid values for Mr. Cordani and other NEOs seen in 2023. By the end of 2023, all SPS awards granted in years 2021, 2022, and 2023 were trending above their targeted adjusted income from operations per share results. |  |  |
Total Shareholder Return Vs Peer Group | Compensation Actually Paid versus Company TSR and Peer Group TSR From 2020 through 2023, Mr. Cordani and the other NEOs’ Compensation Actually Paid amounts were generally aligned with the Company’s absolute TSR and its relative TSR as compared to the peer group used for this Pay Versus Performance analysis, namely the S&P 500 Health Care Index. This is due primarily to the Company’s use of equity incentives, which are tied directly to the Company’s stock price and financial performance on an absolute basis and relative to its peers. In addition, 50% of an SPS award’s payout is aligned to relative TSR performance as compared to a custom peer group, which has changed over time and, for awards granted in 2020 and 2021, differs from the broader S&P 500 Health Care Index. The Company’s TSR underperformed relative to the S&P 500 Health Care Index in 2020 and 2021, leading to annual Compensation Actually Paid values that were lower than their relative Summary Compensation Table values in those fiscal years. In 2022, however, the Company saw significant TSR growth and outperformed the peer group. This stock price growth translated to significantly increased Compensation Actually Paid values for Mr. Cordani and the other NEOs for 2022. The Company’s TSR for 2023 was lower than the Company’s 2022 TSR on an absolute and relative basis, leading to Compensation Actually Paid values that were lower than both the Summary Compensation Table value for 2023 and the 2022 Compensation Actually Paid values. The graph below compares The Cigna Group cumulative TSR to the S&P 500 Index and the S&P 500 Health Care Index for the five-year period ended December 31, 2023, which we believe provides a more fulsome understanding of the Company’s market performance given the longer time horizon. The stock performance shown in the graph is not intended to forecast or be indicative of future performance. *Assumes that the value of the investment in Cigna common stock and each index was $100 on December 31, 2018 and that all dividends were reinvested. |  |  |
Tabular List, Table |
Most Important Company Performance Measures
Adjusted Income from Operations | Affordability and Effectiveness
Adjusted Revenues | Advancing ESG Initiatives
Relative Total Shareholder Return | Cross-Enterprise Leverage
Adjusted Income from Operations per Share |
Total Shareholder Return Amount | $ 154.34 | 167.71 | 114.34 | 101.83
Peer Group Total Shareholder Return Amount | 143.18 | 140.29 | 143.09 | 113.45
Net Income (Loss) | $ 5,164,000,000 | $ 6,704,000,000 | $ 5,370,000,000 | $ 8,458,000,000
Company Selected Measure Amount | uS_Dollar_Per_Share | 25.09 | 23.36 | 20.48 | 18.45
PEO Name | Mr. Cordani |  |  |
Additional 402(v) Disclosure | Reflects “Shareholders’ Net Income” per SEC requirements.Effective January 1, 2023, The Cigna Group adopted amended accounting guidance for long-duration insurance contracts. Fiscal year 2022 and 2021 amounts have been retrospectively adjusted to conform to this new basis of accounting. See Note 2 - Summary of Significant Accounting Policies to The Cigna Group’s consolidated financial statements in the Annual Report on Form 10-K for the year ended December 31, 2023 for additional information. Most Important Measures in Determining FY2023 Compensation Actually Paid The performance measures listed below represent the most important measures The Cigna Group used to determine Named Executive Officer compensation for fiscal year 2023. The use of each measure is further described in the Compensation Discussion and Analysis (CD&A) within the section titled “Elements of Compensation.” |  |  |
PEO Ratio Of Compensation Paid To Summary Compensation | 39.00% | 274.00% | 78.00% | 80.00%
Non-PEO NEO Ratio Of Compensation Paid To Summary Compensation | 52.00% | 244.00% | 73.00% | 84.00%
PEO Salary | $ 1,500,000 | $ 1,500,000 | $ 1,500,000 | $ 1,500,000
PEO Stock Awards | 15,856,233 | 15,544,307 | 15,370,427 | 14,560,254
PEO Bonus And Non-Equity Incentive Compensation | 3,300,000 | 3,600,000 | 2,700,000 | 3,500,000
PEO Other Compensation | 310,437 | 321,197 | 301,839 | 179,341
PEO Change In Pension Value And Nonqualified Deferred Compensation Earnings | 80,585 | 0 | 0 | 189,898
Non-PEO NEO Salary | 875,288 | 827,549 | 995,385 | 1,001,923
Non-PEO NEO Stock Awards | 4,500,529 | 4,236,986 | 4,731,519 | 4,503,476
Non-PEO NEO Bonus And Non-Equity Incentive Compensation | 1,365,000 | 1,230,625 | 604,500 | 1,470,625
Non-PEO NEO Other Compensation | 50,046 | 51,392 | 829,680 | 55,835
Non-PEO NEO Change In Pension Value And Nonqualified Deferred Compensation Earnings | $ 10,466 | 0 | 3,131 | 43,903
Measure:: 1 |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Name | Adjusted Income from Operations |  |  |
Measure:: 2 |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Name | Adjusted Revenues |  |  |
Measure:: 3 |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Name | Relative Total Shareholder Return |  |  |
Measure:: 4 |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Name | Adjusted Income from Operations per Share |  |  |
Non-GAAP Measure Description | For purposes of this section, we have identified Adjusted Income from Operations, per share as our Company-Selected Measure, the calculation of which is described in our Annual Report on Form 10-K for the year ended December 31, 2023. Additional information regarding our use of non-GAAP measures and reconciliations to the most directly comparable GAAP measure can be found on Annex A. |  |  |
Measure:: 5 |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Name | Affordability and Effectiveness |  |  |
Measure:: 6 |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Name | Advancing ESG Initiatives |  |  |
Measure:: 7 |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Name | Cross-Enterprise Leverage |  |  |
PEO | Deductions [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment to Compensation, Amount | $ (15,856,233) | (15,544,307) | (15,370,427) | (14,560,254)
PEO | Additions [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment to Compensation, Amount | 2,962,236 | 51,967,797 | 10,947,067 | 10,503,298
PEO | Fair Value Of Awards Granted In Current Year, Outstanding And Unvested, Stock Options [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment To Compensation Amount, Equity Awards | 3,106,749 | 7,876,809 | 4,385,246 | 3,749,535
PEO | Change In Fair Value Of Awards From Prior Years, Outstanding And Unvested, Stock Options [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment To Compensation Amount, Equity Awards | (2,098,800) | 6,875,723 | 382,720 | (241,674)
PEO | Change In Fair Value Of Awards, Vested, Stock Options [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment To Compensation Amount, Equity Awards | (2,374,503) | 444,986 | (555,181) | (1,637,861)
PEO | Fair Value Of Awards, Forfeited Or Cancelled, Stock Options [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment To Compensation Amount, Equity Awards | 0 | 0 | 0 | 0
PEO | Equity Award Adjustments, Stock Options [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment To Compensation Amount, Equity Awards | (1,366,555) | 15,197,518 | 4,212,785 | 1,870,000
PEO | Fair Value Of Awards Granted In Current Year, Outstanding And Unvested, Restricted Stock [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment To Compensation Amount, Equity Awards | 3,252,626 | 4,232,869 | 3,893,606 | 3,794,705
PEO | Change In Fair Value Of Awards From Prior Years, Outstanding And Unvested, Restricted Stock [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment To Compensation Amount, Equity Awards | (451,849) | 1,767,720 | 392,213 | 45,261
PEO | Change In Fair Value Of Awards, Vested, Restricted Stock [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment To Compensation Amount, Equity Awards | (640,466) | 38,838 | 26,005 | (114,871)
PEO | Fair Value Of Awards, Forfeited Or Cancelled, Restricted Stock [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment To Compensation Amount, Equity Awards | 0 | 0 | 0 | 0
PEO | Equity Award Adjustments, Restricted Stock [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment To Compensation Amount, Equity Awards | 2,160,310 | 6,039,426 | 4,311,824 | 3,725,095
PEO | Fair Value Of Awards Granted In Current Year, Outstanding And Unvested, Strategic Perf Shares [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment To Compensation Amount, Equity Awards | 8,773,351 | 17,751,119 | 6,977,016 | 7,929,201
PEO | Change In Fair Value Of Awards From Prior Years, Outstanding And Unvested, Strategic Perf Shares [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment To Compensation Amount, Equity Awards | (5,212,929) | 12,979,546 | (4,619,317) | (1,965,506)
PEO | Change In Fair Value Of Awards, Vested, Strategic Perf Shares [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment To Compensation Amount, Equity Awards | (1,391,941) | 188 | 64,758 | (1,055,492)
PEO | Fair Value Of Awards, Forfeited Or Cancelled, Strategic Perf Shares [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment To Compensation Amount, Equity Awards | 0 | 0 | 0 | 0
PEO | Equity Award Adjustments, Strategic Perf Shares [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment To Compensation Amount, Equity Awards | 2,168,481 | 30,730,853 | 2,422,457 | 4,908,203
PEO | Fair Value Of Awards Granted In Current Year, Outstanding And Unvested [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment To Compensation Amount, Equity Awards | 15,132,725 | 29,860,797 | 15,255,868 | 15,473,441
PEO | Change In Fair Value Of Awards From Prior Years, Outstanding And Unvested [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment To Compensation Amount, Equity Awards | (7,763,578) | 21,622,989 | (3,844,384) | (2,161,919)
PEO | Change In Fair Value Of Awards, Vested [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment To Compensation Amount, Equity Awards | (4,406,911) | 484,012 | (464,418) | (2,808,224)
PEO | Fair Value Of Awards, Forfeited Or Cancelled [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment To Compensation Amount, Equity Awards | 0 | 0 | 0 | 0
Non-PEO NEO | Deductions [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment to Compensation, Amount | (4,500,529) | (4,236,986) | (4,731,519) | (4,503,476)
Non-PEO NEO | Additions [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment to Compensation, Amount | 1,220,332 | 13,387,296 | 2,799,802 | 3,383,009
Non-PEO NEO | Fair Value Of Awards Granted In Current Year, Outstanding And Unvested, Stock Options [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment To Compensation Amount, Equity Awards | 1,100,520 | 2,714,064 | 1,349,900 | 1,159,710
Non-PEO NEO | Change In Fair Value Of Awards From Prior Years, Outstanding And Unvested, Stock Options [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment To Compensation Amount, Equity Awards | (639,461) | 1,556,183 | 84,814 | (52,264)
Non-PEO NEO | Change In Fair Value Of Awards, Vested, Stock Options [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment To Compensation Amount, Equity Awards | (594,895) | 91,685 | (143,363) | (444,007)
Non-PEO NEO | Fair Value Of Awards, Forfeited Or Cancelled, Stock Options [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment To Compensation Amount, Equity Awards | 0 | 0 | 0 | 0
Non-PEO NEO | Equity Award Adjustments, Stock Options [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment To Compensation Amount, Equity Awards | (133,836) | 4,361,932 | 1,291,351 | 663,439
Non-PEO NEO | Fair Value Of Awards Granted In Current Year, Outstanding And Unvested, Restricted Stock [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment To Compensation Amount, Equity Awards | 1,152,358 | 1,458,559 | 1,198,577 | 1,173,719
Non-PEO NEO | Change In Fair Value Of Awards From Prior Years, Outstanding And Unvested, Restricted Stock [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment To Compensation Amount, Equity Awards | (138,275) | 444,168 | 132,175 | 35,275
Non-PEO NEO | Change In Fair Value Of Awards, Vested, Restricted Stock [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment To Compensation Amount, Equity Awards | (182,536) | 36,761 | (345,777) | (56,462)
Non-PEO NEO | Fair Value Of Awards, Forfeited Or Cancelled, Restricted Stock [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment To Compensation Amount, Equity Awards | 0 | 0 | 0 | 0
Non-PEO NEO | Equity Award Adjustments, Restricted Stock [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment To Compensation Amount, Equity Awards | 831,548 | 1,939,488 | 984,975 | 1,152,532
Non-PEO NEO | Fair Value Of Awards Granted In Current Year, Outstanding And Unvested, Strategic Perf Shares [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment To Compensation Amount, Equity Awards | 2,071,979 | 4,077,759 | 1,861,457 | 2,452,495
Non-PEO NEO | Change In Fair Value Of Awards From Prior Years, Outstanding And Unvested, Strategic Perf Shares [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment To Compensation Amount, Equity Awards | (1,252,141) | 3,008,083 | (1,240,350) | (533,442)
Non-PEO NEO | Change In Fair Value Of Awards, Vested, Strategic Perf Shares [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment To Compensation Amount, Equity Awards | (297,218) | 33 | 49,621 | (352,015)
Non-PEO NEO | Fair Value Of Awards, Forfeited Or Cancelled, Strategic Perf Shares [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment To Compensation Amount, Equity Awards | 0 | 0 | 147,252 | 0
Non-PEO NEO | Equity Award Adjustments, Strategic Perf Shares [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment To Compensation Amount, Equity Awards | 522,621 | 7,436,426 | 523,476 | 1,567,038
Non-PEO NEO | Fair Value Of Awards Granted In Current Year, Outstanding And Unvested [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment To Compensation Amount, Equity Awards | 4,324,857 | 8,250,382 | 4,409,934 | 4,785,924
Non-PEO NEO | Change In Fair Value Of Awards From Prior Years, Outstanding And Unvested [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment To Compensation Amount, Equity Awards | (2,029,877) | 5,008,434 | (1,023,361) | (550,431)
Non-PEO NEO | Change In Fair Value Of Awards, Vested [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment To Compensation Amount, Equity Awards | (1,074,648) | 128,479 | (439,519) | (852,484)
Non-PEO NEO | Fair Value Of Awards, Forfeited Or Cancelled [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment To Compensation Amount, Equity Awards | $ 0 | $ 0 | $ 147,252 | $ 0

X
- References No definition available. + Details
Name: | ci_AdjustmentToCompensationAmountEquityAwards
Namespace Prefix: | ci_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | ci_NonPEONEOBonusAndNonEquityIncentiveCompensation
Namespace Prefix: | ci_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | ci_NonPEONEOChangeInPensionValueAndNonqualifiedDeferredCompensationEarnings
Namespace Prefix: | ci_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | ci_NonPEONEOOtherCompensation
Namespace Prefix: | ci_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | ci_NonPEONEORatioOfCompensationPaidToSummaryCompensation
Namespace Prefix: | ci_
Data Type: | dtr-types1:percentItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ci_NonPEONEOSalary
Namespace Prefix: | ci_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | ci_NonPEONEOStockAwards
Namespace Prefix: | ci_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | ci_PEOBonusAndNonEquityIncentiveCompensation
Namespace Prefix: | ci_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | ci_PEOChangeInPensionValueAndNonqualifiedDeferredCompensationEarnings
Namespace Prefix: | ci_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | ci_PEOOtherCompensation
Namespace Prefix: | ci_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | ci_PEORatioOfCompensationPaidToSummaryCompensation
Namespace Prefix: | ci_
Data Type: | dtr-types1:percentItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ci_PEOSalary
Namespace Prefix: | ci_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | ci_PEOStockAwards
Namespace Prefix: | ci_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v + Details
Name: | ecd_Additional402vDisclosureTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_AdjToCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_AdjToNonPeoNeoCompFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_AdjToPeoCompFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_CoSelectedMeasureAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_CoSelectedMeasureName
Namespace Prefix: | ecd_
Data Type: | xbrli:normalizedStringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph iii + Details
Name: | ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph ii + Details
Name: | ecd_CompActuallyPaidVsNetIncomeTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph i + Details
Name: | ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_MeasureName
Namespace Prefix: | ecd_
Data Type: | xbrli:normalizedStringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_NamedExecutiveOfficersFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_NonGaapMeasureDescriptionTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iii + Details
Name: | ecd_NonPeoNeoAvgCompActuallyPaidAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph ii + Details
Name: | ecd_NonPeoNeoAvgTotalCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iv + Details
Name: | ecd_PeerGroupIssuersFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iv + Details
Name: | ecd_PeerGroupTotalShareholderRtnAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iii + Details
Name: | ecd_PeoActuallyPaidCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_PeoName
Namespace Prefix: | ecd_
Data Type: | xbrli:normalizedStringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph ii + Details
Name: | ecd_PeoTotalCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 1 + Details
Name: | ecd_PvpTable
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 1 + Details
Name: | ecd_PvpTableTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 6 + Details
Name: | ecd_TabularListTableTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iv + Details
Name: | ecd_TotalShareholderRtnAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph iv + Details
Name: | ecd_TotalShareholderRtnVsPeerGroupTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4 Reference 13: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section 45 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(18)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(9)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(1)(d)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B Reference 29: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30 Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 Reference 31: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 60B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B Reference 32: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31 Reference 33: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 Reference 34: http://www.xbrl.org/2003/role/disclosureRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7 Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28 Reference 36: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A Reference 37: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(20)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2 Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(22)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1 + Details
Name: | us-gaap_NetIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | ecd_MeasureAxis=1
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_MeasureAxis=2
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_MeasureAxis=3
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_MeasureAxis=4
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_MeasureAxis=5
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_MeasureAxis=6
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_MeasureAxis=7
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_ExecutiveCategoryAxis=ecd_PeoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ci_DeductionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ci_AdditionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ci_FairValueOfAwardsGrantedInCurrentYearOutstandingAndUnvestedStockOptionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ci_ChangeInFairValueOfAwardsFromPriorYearsOutstandingAndUnvestedStockOptionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ci_ChangeInFairValueOfAwardsVestedStockOptionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ci_FairValueOfAwardsForfeitedOrCancelledStockOptionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ci_EquityAwardAdjustmentsStockOptionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ci_FairValueOfAwardsGrantedInCurrentYearOutstandingAndUnvestedRestrictedStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ci_ChangeInFairValueOfAwardsFromPriorYearsOutstandingAndUnvestedRestrictedStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ci_ChangeInFairValueOfAwardsVestedRestrictedStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ci_FairValueOfAwardsForfeitedOrCancelledRestrictedStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ci_EquityAwardAdjustmentsRestrictedStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ci_FairValueOfAwardsGrantedInCurrentYearOutstandingAndUnvestedStrategicPerfSharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ci_ChangeInFairValueOfAwardsFromPriorYearsOutstandingAndUnvestedStrategicPerfSharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ci_ChangeInFairValueOfAwardsVestedStrategicPerfSharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ci_FairValueOfAwardsForfeitedOrCancelledStrategicPerfSharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ci_EquityAwardAdjustmentsStrategicPerfSharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ci_FairValueOfAwardsGrantedInCurrentYearOutstandingAndUnvestedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ci_ChangeInFairValueOfAwardsFromPriorYearsOutstandingAndUnvestedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ci_ChangeInFairValueOfAwardsVestedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ci_FairValueOfAwardsForfeitedOrCancelledMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |